Results 71 to 80 of about 7,177 (149)
[Advances in research on metabolic associated fatty liver disease in 2025]. [PDF]
Zhonghua Gan Zang Bing Za ZhiRao HY, Zhao JM, Yu CH, Mi YQ, Wei L.
europepmc +1 more source
Zhongshan Daxue xuebao. Yixue kexue ban, 1995 对１２８例有病理诊断依据的肝细胞场（ＨＣＣ）、４７例慢迁肝（ＣＰＨ）、１０５例慢活肝（ＣＡＨ）、４６例肝硬化（ＬＣ）．采用嵌套式ＰＣＲ技术检测其血标本中的丙型肝炎病毒（ＨＣｖ）ＲＮＡ和乙型肝炎病毒（ＨＢＶ）ＤＩＩＡ，对这两种病毒的血清学标志也进行了研究。结果：在ＨＣＣ组。ＨＣＶＲＮＡ１４．１％阳性，ＨＢＶＤＮＡ７ｉ．３％阳性。ＣＰＨ，ＣＡＨ，ＬＣ和ＨＣＣ的ＨＢＶ感染率均在９０％左右，而ＨＣＶ感染率则分别为８．５％、９．５％、１７．４％和１９．５％，显示ＨＣＶ感染率随肝病严重程度的增加而有增加的趋势 ...
doaj
[Reflections on the novel definition and whether or not antiviral therapy for inactive HBsAg carrier state in the "Guidelines for the Prevention and Treatment of Chronic Hepatitis B (version 2022)"]. [PDF]
Zhonghua Gan Zang Bing Za ZhiRen S, Zheng SJ, Chen XY.
europepmc +1 more source
[Research progress in the field of liver failure with artificial livers in 2025]. [PDF]
Zhonghua Gan Zang Bing Za ZhiHan T.
europepmc +1 more source
[Research progress on serum chitinase-3-like protein 1 for diagnosing early-stage liver fibrosis non-invasively]. [PDF]
Zhonghua Gan Zang Bing Za ZhiLi XN, Wang B.
europepmc +1 more source
[Expert consensus on the management process within medical institutions for patients with hepatitis B virus infection]. [PDF]
Zhonghua Gan Zang Bing Za ZhiAuthor Group of Expert Consensus.
europepmc +1 more source
[Analysis of the prevalence status and clinical characteristics of the hepatitis D virus in the Xinjiang region]. [PDF]
Zhonghua Gan Zang Bing Za ZhiWang ZG +14 more
europepmc +1 more source